C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/1997
10/23/1997	WO1997038584A1 Inhibition of endogenous gastrin expression for treatment of colorectal cancer
10/23/1997	WO1997038571A1 Compositions and methods for taxol biosynthesis
10/23/1997	WO1997035005A3 Cftr gene regulator
10/23/1997	WO1997034996A3 Induction quiescence in bacterial cells and uses thereof
10/23/1997	WO1997034137A3 Methods of the identification of pharmaceutically active compounds
10/23/1997	WO1997032019A3 C-c ckr-5, cc-chemikines receptor, derivatives thereof and their uses
10/23/1997	WO1997031114A3 Polynucleotides and aminoacid sequences from staphylococcus aureus
10/23/1997	WO1997030158A3 Recombinant protein containing a c-terminal fragment of plasmodium msp-1
10/23/1997	WO1997026918A3 Ligand directed enzyme prodrug therapy
10/23/1997	WO1997026853A3 Dna encoding galanin galr2 receptors and uses thereof
10/23/1997	WO1997025068A3 Mesothelin antigen and methods and kits for targeting it
10/23/1997	WO1997023634A3 Production of true-breeding transgenic seeds from plants heterozygous for transgene insertions
10/23/1997	WO1997021812A3 Mammalian chemokine ccf8 and chemokine receptor cckr3
10/23/1997	WO1997014798A3 Polynucleotides and proteins coded thereby useful for controlling melolontha sp. cockchafers
10/23/1997	WO1997014789A3 Enzymatic array and process of making same
10/23/1997	WO1997012992A3 Diagnosis method for a disease caused by a frameshift mutation in a gene and reagents therefore
10/23/1997	DE19616381C1 Nachweis numerischer Veränderungen in der DNA von Zellen Detecting numerical changes in the DNA of cells
10/23/1997	DE19615803A1 CELO-Virus CELO virus
10/23/1997	DE19615710A1 Verfahren zur Gewinnung und Anwendung eines biologisch aktiven Eiweisstoffes - Kollagenfragment HF-COLL-18/514cf - in partiell aufgereinigter und synthetischer Form aus Körperflüssigkeiten zur Beeinflussung des Zellwachstums und der Diagnose von Kollagenerkrankungen sowie der Osteoporose Methods for obtaining and application of a biologically active Eiweisstoffes - collagen fragment HF-COLL-18 / 514cf - in partially purified form from body fluids and synthetic for influencing the cell growth and the diagnosis of collagen diseases and osteoporosis
10/23/1997	CA2252225A1 Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection
10/23/1997	CA2252082A1 Hybrid interferon compositions and methods of use
10/23/1997	CA2251945A1 Antisense inhibitors of vascular endothelial growth factor (vefg/vpf) expression
10/23/1997	CA2251904A1 An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof
10/23/1997	CA2251818A1 Mammalian genes involved in viral infection and tumor suppression
10/23/1997	CA2251786A1 Food products containing structured triglycerides
10/23/1997	CA2251745A1 Non-a-non-e hepatitis virus having a translatable core region, reagents and methods for their use
10/23/1997	CA2251738A1 Targeted viral vectors
10/23/1997	CA2251631A1 Intestinal trefoil proteins
10/23/1997	CA2251613A1 Novel plant steroid 5.alpha. reductase, det2
10/23/1997	CA2251588A1 Biologically active fragment of bacillus stearothermophilus dna polymerase
10/23/1997	CA2251543A1 Novel cationic cholesteryl derivatives containing cyclic polar groups
10/23/1997	CA2251115A1 Novel rantes homolog from prostate
10/23/1997	CA2250975A1 Soluble 7-transmembrane domain g-protein-coupled receptor compositions and methods
10/23/1997	CA2250707A1 Cysteine-containing or methionine-containing peptides with immunomodulatory effects
10/23/1997	CA2241051A1 Targeted therapeutic or diagnostic agents and methods of making and using same
10/23/1997	CA2224571A1 Cytoplasmic modulators of integrin regulation/signaling
10/22/1997	EP0802259A1 Cyclodextrin glucosyltransferases for the production of gamma-cyclodextrin
10/22/1997	EP0802258A2 Method of synthesizing polydeoxyribonucleotides, method of synthesizing chromosomal DNA and method of producing chromosomes
10/22/1997	EP0801689A1 Method of screening for genetic predisposition to anticholinesterase therapy
10/22/1997	EP0801682A1 Process for the production of proteins
10/22/1997	EP0801681A1 Transgenic plants expressing acc synthase gene
10/22/1997	EP0801680A2 PRODUCTION OF GAMMA LINOLENIC ACID BY A $g(D)6-DESATURASE
10/22/1997	EP0801679A1 Monoclonal antibodies which promote central nervous system remyelination
10/22/1997	EP0801678A1 Recombinant swinepox virus
10/22/1997	EP0801676A2 New artificial tissue, method for the production and the use thereof
10/22/1997	EP0801658A1 Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples
10/22/1997	EP0801657A1 Retinoid x receptor-interacting polypeptides and related molecules and methods
10/22/1997	EP0801649A2 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
10/22/1997	EP0801575A1 Retroviral vectors for expression in embryonic cells
10/22/1997	EP0801574A1 Modulation of integrin-mediated signal transduction
10/22/1997	EP0801526A1 Gene transduction system
10/22/1997	EP0778890A4 Dna encoding a human calcium channel alpha-1e subunit
10/22/1997	EP0693122A4 Glutamylcysteine synthetase light subunit
10/22/1997	EP0576426B1 Ryegrass pollen allergen
10/22/1997	EP0557459B1 Bifunctional selectable fusion genes
10/22/1997	EP0551449B1 Method for producing a subunit vaccine against porcine parvovirus
10/22/1997	EP0491033B1 Isolation and purification of lung surfactant protein
10/22/1997	EP0228458B2 Epithelial cells expressing foreign genetic material
10/22/1997	CN1162979A DNA sequence and its use
10/22/1997	CN1162978A Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
10/22/1997	CN1162977A Modified Factor VII
10/22/1997	CN1162976A Process for producing L-valine and L-leucine
10/22/1997	CN1162743A Method of analysis or assay for polynucleotides and analyzer or instrument for polynucleotides
10/22/1997	CN1162643A Preparation and usage of molecular chimera for curing cancer
10/22/1997	CN1162642A Preparation of reagent for bisexual protein transfecting pharmaceutics
10/22/1997	CN1162641A Cyclodextrin glycosyl transferases for producing r-cyclodextrin
10/21/1997	US5679881 Free from intact plant cells; capable of catalyzing production of very long chain fatty acids
10/21/1997	US5679880 Oral immunization by transgenic plants
10/21/1997	US5679784 Recombinant dna molecule comprising adenylate cyclase gene of bordetella
10/21/1997	US5679783 Chordin polypeptide capable of inducing dorsal and neural tissue development in vertebrates; neurotropic growth factor
10/21/1997	US5679782 Inhibit receptor binding activity of urokinase-type plasminogen activator
10/21/1997	US5679777 Time-release agents comprising conjugates of genetically engineered proteins as drug carriers; enhanced stability; increased vascular retention
10/21/1997	US5679774 DNA sequences of the EBV genome, recombinant DNA molecules, processes for preparing EBV-related antigens, diagnostic compositions and pharmaceutical compositions containing said antigens
10/21/1997	US5679772 Medical diagnosis, immunoassays
10/21/1997	US5679768 Epitopic regions of pneumococcal surface protein A
10/21/1997	US5679647 Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
10/21/1997	US5679630 Protease-containing cleaning compositions
10/21/1997	US5679571 Heat resistance
10/21/1997	US5679566 Yeast NMD2 gene
10/21/1997	US5679560 Genes for the synthesis of antipathogenic substances
10/21/1997	US5679559 Cationic polymer and lipoprotein-containing system for gene delivery
10/21/1997	US5679558 Transformation of monocot cells
10/21/1997	US5679555 Method of using ribozyme analogs having rigid, non-nucleotidic molecular linkers
10/21/1997	US5679554 Finderons and methods of their preparation and use
10/21/1997	US5679553 Process for rendering a nucleic acid amplication reaction product incapable of being a target for further amplification, a diagnostic assay employing said process
10/21/1997	US5679552 A recombinant nucleic acid sequence encoding an aminoterminal extended human growth hormone, the extension of which contains a charged amino acid, e.g. glutamic or aspartic acid; methionine-free
10/21/1997	US5679551 Genetic engineering; insertion of genetic vector
10/21/1997	US5679550 Polypeptides; anticarcinogenic agents
10/21/1997	US5679549 Production of recombinant factor VIII in the presence of liposome-like substances of mixed composition
10/21/1997	US5679548 Inducing mutagenesis of a complementarity determining region (cdr) of an immunoglobulin heavy or light chain gene; amplification of the cdr; genetic engineering
10/21/1997	US5679546 Chimeric proteins which block complement activation
10/21/1997	US5679545 Therapy for heart failure, arrhythmic, inotropic and neurological disorders
10/21/1997	US5679544 Modified Kluyveromyces yeasts, their preparation and use
10/21/1997	US5679543 DNA sequences, vectors and fusion polypeptides to increase secretion of desired polypeptides from filamentous fungi
10/21/1997	US5679542 Antithrombosis agents
10/21/1997	US5679541 Programmed cell death antagonist protein
10/21/1997	US5679540 Cloning and identification of a two component signal transducing regulatory system from bacteroides fragilis
10/21/1997	US5679533 Biotin-binding containment systems
10/21/1997	US5679531 Methods of detecting βA4 peptide species ending at carboxy-terminus residue 42 using monoclonal antibody 369.2B
10/21/1997	US5679530 Immunogenic complex of isolated polypeptides of specific amino acid sequence to a keyhole lampet hemocyanin

1 ... 3589 3590 3591 3592 3593 3594 3595 3596 3597 3598 3599 3600 3601 3602 3603 3604 3605 3606 3607 3608 3609 ... 4023